CLASSIFICATION
Melanocortin Receptor Agonists
ACNE
No
WATER RETENTION
No
HBR
No
HEPATOTOXICITY
No
AROMATIZATION
No
MANUFACTURER
Beligas
WAREHOUSE
International Warehouse 3
SUBSTANCE
Bremelanotide
,
PT-141 (Bremelanotide) is a well-known peptide primarily aimed at enhancing libido. One of its key characteristics is that it is suitable for both men and women. Despite being synthetically produced, PT-141 is deemed completely safe. It can be prescribed to men experiencing erectile dysfunction and to women facing sexual disorders.
Research has uncovered additional benefits of PT-141. This peptide is known to promote melanin production, leading to a pronounced tanning effect. Consequently, ongoing laboratory research continues to explore new uses for this peptide.
Both men and women utilize PT-141. Unlike medications such as Viagra and Cialis, which primarily target blood vessels, Bremelanotide's active ingredients also enhance libido directly.
Effects of PT-141 Use:To achieve optimal results, please review the PT-141 instructions carefully.
Usage and Dosage of PT-141:For initial effects, a subcutaneous injection of 0.3 milligrams is recommended. This starting dose helps gauge the active components' impact on the body. If needed, the dosage can be adjusted upward, with an optimal range for a single dose between 0.5 and 1.5 milligrams.
The initial signs of Bremelanotide’s effectiveness typically emerge within a couple of hours post-injection, reaching peak effect at around 3-4 hours, and lasting for approximately 8-10 hours.
Side Effects and Contraindications:Studies have confirmed that Bremelanotide exhibits all the mentioned properties in the instructions and fulfills its intended purpose effectively. However, some participants reported elevated blood pressure, which led to the suspension of the study. Feedback regarding PT-141 also indicates that overdosing could adversely affect blood pressure and potentially lead to hypertension. Additionally, users should be aware of possible localized reactions, such as redness at the injection site, which usually resolves within minutes and is not considered a serious complication.